Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Topiramate 30mg/5ml oral liquid
040801050AABLBL
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 35mg/5ml oral liquid
040801050AABRBR
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 5mg/5ml oral liquid
040801050AABIBI
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 6.25mg/5ml oral liquid
040801050AABHBH
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 62.5mg/5ml oral suspension
040801050AACDCD
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 67.5mg/5ml oral liquid
040801050AABUBU
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 75mg/5ml oral liquid
040801050AAASAS
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 8mg/5ml oral suspension
040801050AACFCF
|
Topiramate | Topiramate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.